title: Modulation of membrane phospholipids, the cytosolic calcium influx and cell proliferation following treatment of B16-F10 cells with recombinant phospholipase-D from Loxosceles intermedia (brown spider) venom.
abstract: The mechanism through which brown spiders (Loxosceles genus) cause dermonecrosis, dysregulated inflammatory responses, hemolysis and platelet aggregation, which are effects reported following spider bites, is currently attributed to the presence of phospholipase-D in the venom. In the present investigation, through two-dimensional immunoblotting, we observed immunological cross-reactivity for at least 25 spots in crude Loxosceles intermedia venom, indicating high expression levels for different isoforms of phospholipase-D. Using a recombinant phospholipase-D from the venom gland of L. intermedia (LiRecDT1) in phospholipid-degrading kinetic experiments, we determined that this phospholipase-D mainly hydrolyzes synthetic sphingomyelin in a time-dependent manner, generating ceramide 1-phosphate plus choline, as well as lysophosphatidylcholine, generating lysophosphatidic acid plus choline, but exhibits little activity against phosphatidylcholine. Through immunofluorescence assays with antibodies against LiRecDT1 and using a recombinant GFP-LiRecDT1 fusion protein, we observed direct binding of LiRecDT1 to the membrane of B16-F10 cells. We determined that LiRecDT1 hydrolyzes phospholipids in detergent extracts and from ghosts of B16-F10 cells, generating choline, indicating that the enzyme can access and modulate and has activity against membrane phospholipids. Additionally, using Fluo-4, a calcium-sensitive fluorophore, it was shown that treatment of cells with phospholipase-D induced an increase in the calcium concentration in the cytoplasm, but without altering viability or causing damage to cells. Finally, based on the known endogenous activity of phospholipase-D as an inducer of cell proliferation and the fact that LiRecDT1 binds to the cell surface, hydrolyzing phospholipids to generate bioactive lipids, we employed LiRecDT1 as an exogenous source of phospholipase-D in B16-F10 cells. Treatment of the cells was effective in increasing their proliferation in a time- and concentration-dependent manner, especially in the presence of synthetic sphingomyelin in the medium. The results described herein indicate the ability of brown spider phospholipase-D to induce the generation of bioactive phospholipids, calcium influx into the cytoplasm and cell proliferation, suggesting that this molecule can be used as a bioactive tool for experimental protocols in cell biology.
authors: Department of Cell Biology, Federal University of Paraná, Jardim das Américas, 81531-990 Curitiba, Paraná, Brazil.
authors: Ana Carolina Martins
authors: AC
authors: Wille
authors: Daniele
authors: D
authors: Chaves-Moreira
authors: Dilza
authors: D
authors: Trevisan-Silva
authors: Mariana Gabriel
authors: MG
authors: Magnoni
authors: Marianna
authors: M
authors: Boia-Ferreira
authors: Luiza Helena
authors: LH
authors: Gremski
authors: Waldemiro
authors: W
authors: Gremski
authors: Olga Meiri
authors: OM
authors: Chaim
authors: Andrea
authors: A
authors: Senff-Ribeiro
authors: Silvio Sanches
authors: SS
authors: Veiga
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D063287:Brown Recluse Spider; D020013:Calcium Signaling / Q000187:drug effects*; D045744:Cell Line, Tumor; D002462:Cell Membrane / Q000187:drug effects / Q000378:metabolism; D049109:Cell Proliferation / Q000187:drug effects; D002470:Cell Survival / Q000187:drug effects; D002794:Choline / Q000378:metabolism; D003600:Cytosol / Q000187:drug effects / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D004354:Drug Screening Assays, Antitumor; D006801:Humans; D008546:Melanoma, Experimental / Q000188:drug therapy* / Q000378:metabolism; D010739:Phospholipase D / Q000494:pharmacology*; D010743:Phospholipids / Q000378:metabolism*; D010727:Phosphoric Diester Hydrolases; D011994:Recombinant Proteins / Q000494:pharmacology; D012697:Serine Endopeptidases / Q000378:metabolism*; D013109:Sphingomyelins / Q000378:metabolism; D013111:Spider Venoms / Q000201:enzymology*
chemical_list: D000970:Antineoplastic Agents; D010743:Phospholipids; D011994:Recombinant Proteins; D013109:Sphingomyelins; D013111:Spider Venoms; C055161:loxosceles venom; D010727:Phosphoric Diester Hydrolases; D010739:Phospholipase D; D012697:Serine Endopeptidases; D002794:Choline